EcoDrugPlus

Retinoic Acid Receptor Beta

Ensembl ID : ENSCHYG00000011336
Gene Symbol: RARB
1 Cross references
451 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSCHYG00000000032
Gene Symbol: RARG
1 Cross references
451 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSCHYG00000012646
Gene Symbol: RXRA
1 Cross references
249 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSCHYG00000004811
Gene Symbol: RXRG
1 Cross references
277 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSCHYG00000008204
Gene Symbol: RPL11
1 Cross references
209 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSCHYG00000000169
Gene Symbol: RPL18
1 Cross references
296 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSCHYG00000001837
Gene Symbol: RPL19
1 Cross references
237 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSCHYG00000023371
Gene Symbol: RPL22
1 Cross references
225 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSCHYG00000021940
Gene Symbol: RPL24
1 Cross references
220 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSCHYG00000013616
Gene Symbol: RPL27
1 Cross references
136 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSCHYG00000003285
Gene Symbol: RPL27A
1 Cross references
199 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSCHYG00000005137
Gene Symbol: RPL30
1 Cross references
188 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).